Literature DB >> 7908671

PCR-based restriction fragment length polymorphism typing of Helicobacter pylori.

S Fujimoto1, B Marshall, M J Blaser.   

Abstract

We applied a molecular typing approach for Helicobacter pylori that uses restriction fragment length polymorphism (RFLP) analyses of an 820-bp PCR-amplified portion of the ureC gene in H. pylori. The PCR products were digested with restriction enzyme HhaI, MboI, or MseI, and the fragments generated were analyzed by agarose electrophoresis. Among 25 independent clinical isolates, each showed a different pattern when a combination of the three RFLP patterns was used. Using this method, we studied isolates from the antrum or the body of the stomach of 14 patients before and after antibiotic therapy. Before treatment, successful isolation of H. pylori from the two sites of the stomach was possible for 12 of the 14 patients. For 10 of these 12 patients, each pair of isolates had identical RFLP profiles. For the other two patients (16.7%), however, isolates from the antrum and the body of the stomach had different RFLP profiles. Treatment was successful for 6 of the 14 patients; of the 8 patients with treatment failures, 5 had identical isolate pairs. In each case, the isolates found posttreatment were the same as the pretreatment isolates. For one of the patients who was colonized with two different isolates pretreatment, one of the isolates was identified at both sites after unsuccessful treatment. We also studied six long-term follow-up patients who had sequential biopsies at intervals of up to 5 months. Each follow-up isolate from each patient had the same RFLP profile as the initial isolate. This typing method provides a reliable and reproducible typing scheme for the study of H. pylori infections and indicates that infection with more than one H. pylori isolate is not rare.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908671      PMCID: PMC263033          DOI: 10.1128/jcm.32.2.331-334.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Evidence of gastritis with several Helicobacter pylori strains.

Authors:  A Beji; P Vincent; I Darchis; M O Husson; A Cortot; H Leclerc
Journal:  Lancet       Date:  1989-12-09       Impact factor: 79.321

2.  Demonstration of plasmids in Campylobacter pylori.

Authors:  S S Penfold; A J Lastovica; B G Elisha
Journal:  J Infect Dis       Date:  1988-04       Impact factor: 5.226

3.  Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only.

Authors:  N Figura; P Guglielmetti; A Rossolini; A Barberi; G Cusi; R A Musmanno; M Russi; S Quaranta
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

4.  Immunoblot fingerprinting of Campylobacter pylori.

Authors:  J P Burnie; W Lee; J C Dent; C A McNulty
Journal:  J Med Microbiol       Date:  1988-10       Impact factor: 2.472

5.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

Review 6.  Campylobacter pylori: its link to gastritis and peptic ulcer disease.

Authors:  B J Marshall
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

7.  Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis.

Authors:  W Langenberg; E A Rauws; A Widjojokusumo; G N Tytgat; H C Zanen
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

8.  Typing of Campylobacter pylori by bacterial DNA restriction endonuclease analysis and determination of plasmid profile.

Authors:  A E Simor; B Shames; B Drumm; P Sherman; D E Low; J L Penner
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

9.  Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial.

Authors:  W L Peterson; D Y Graham; B Marshall; M J Blaser; R M Genta; P D Klein; C W Stratton; J Drnec; P Prokocimer; N Siepman
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

10.  Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation.

Authors:  S I Majewski; C S Goodwin
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

View more
  36 in total

1.  Phenotypic and genotypic variation in methylases involved in type II restriction-modification systems in Helicobacter pylori.

Authors:  Tohru Takata; Rahul Aras; Donald Tavakoli; Takafumi Ando; Asalia Z Olivares; Martin J Blaser
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

2.  High-level genetic diversity in the vapD chromosomal region of Helicobacter pylori.

Authors:  P Cao; T L Cover
Journal:  J Bacteriol       Date:  1997-05       Impact factor: 3.490

3.  Genotypic and phenotypic diversity within species of purple nonsulfur bacteria isolated from aquatic sediments.

Authors:  Yasuhiro Oda; Wouter Wanders; Louis A Huisman; Wim G Meijer; Jan C Gottschal; Larry J Forney
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

4.  Development of a scheme for genotyping Helicobacter pylori based on allelic variation in urease subunit genes.

Authors:  R J Owen; E R Slater; J Xerry; T M Peters; E L Teare; A Grant
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

Review 5.  Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes.

Authors:  H X Xia; N J Talley; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

6.  A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori.

Authors:  G G Stone; D Shortridge; J Versalovic; J Beyer; R K Flamm; D Y Graham; A T Ghoneim; S K Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

7.  Helicobacter pylori isolated from a patient with Ménétrier's disease increases hepatocyte growth factor mRNA expression in gastric fibroblasts: comparison with Helicobacter pylori isolated from other gastric diseases.

Authors:  Takeshi Ishikawa; Takashi Ando; Hiroshi Obayashi; Nami Nakabe; Mika Okita; Yutaka Isozaki; Yasuyuki Nagao; Hirokazu Oyamada; Yoshihiro Nakajima; Haruki Kato; Satoshi Kokura; Yuji Naito; Norimasa Yoshida; Toshikazu Yoshikawa
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

8.  Adaptive mutation and cocolonization during Helicobacter pylori infection of gnotobiotic piglets.

Authors:  N S Akopyants; K A Eaton; D E Berg
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Detection of Helicobacter pylori in gastric mucosa of patients with gastroduodenal diseases by PCR-restriction analysis using the RNA polymerase gene (rpoB).

Authors:  Chang-Young Lim; Keun-Hwa Lee; Myung-Je Cho; Myung-Woong Chang; Seok-Yong Kim; Na-Hye Myong; Woo-Kon Lee; Kwang-Ho Rhee; Yoon-Hoh Kook
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Evaluation of nested PCR in detection of Helicobacter pylori targeting a highly conserved gene: HSP60.

Authors:  Varsha Singh; Shrutkirti Mishra; G R K Rao; Ashok Kumar Jain; V K Dixit; Anil Kumar Gulati; Divya Mahajan; Michael McClelland; Gopal Nath
Journal:  Helicobacter       Date:  2008-02       Impact factor: 5.753

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.